CHITOSE is pleased to announce its participation in BioProcess International (BPI) 2026, held from September 22nd to September 25th, 2026, at the Hynes Convention Center in Boston.

General Manager Dr. Riztyan, will deliver a technical presentation detailing our recent work demonstrating high-density seeding strategies and high-yield antibody production using CHITOSE’s proprietary CHO-MK platform in Thermo FisherTM DynaDrive™ 5L Single-Use Bioreactor (S.U.B.).

Presentation
• Title: High-Yield CHO-MK Cell Culture Through High-Density Seeding in DynaDrive™ Bioreactor
• Time: Wednesday, September 23rd, 2026 | 4:40 PM – 5:00 PM
• Presenter: Dr. Riztyan (General Manager, Tech & Biz Development Div.)

Contact
biologics.contact◎chitose-bio.com
*replace ◎ with @

Event Overview
• Event Name: BioProcess International (BPI) 2026
• Dates: September 22–25, 2026
• Location: Hynes Convention Center, Boston, MA

About CHITOSE’s Cell Line Development Service
https://biologics.chitose-bio.com/
Through over 10 years of research, CHITOSE has developed the highly productive CHO-MK host cell line and designed the original Chitose Super CHO expression system (CS CHO). With the combination of these innovations, we have established an extremely robust and flexible system to address the needs for a faster and more cost-effective cell line-based protein expression platform.